Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 5, 1998, Pages 541-548

  Barchiesi, F ^a   Arzeni, D ^a   Del Prete, M S ^a   Sinicco, A ^b   Falconi Di Francesco, L ^a   Pasticci, M B ^c   Lamura, L ^a   Nuzzo, M M ^a   Burzacchini, F ^d   Coppola, S ^e   Chiodo, F ^f   Scalise, G ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d Azienda Ospedaliera Umberto I   (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; PENICILLIN G;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SENSITIVITY; ELECTROPHORESIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KARYOTYPING; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; SEROTYPING;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; ELECTROPHORESIS, AGAR GEL; FEMALE; FLUCONAZOLE; HUMANS; KARYOTYPING; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 15644367673     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.5.541     Document Type: Article

References (41)

1. Klein, R. S., Harris, C. A., Small, C. B., Moll, B., Lesser, M. & Friedland, G. H. (1984). Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. New England Journal of Medicine 311, 354-8.
2. Feigal, D. W., Katz, M. H., Greenspan, D., Westenhouse, J., Winkelstein, W., Lang, W. et al. (1991). The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 5, 519-25.
3. Torssander, J., Morfeldt-Månson, L., Biberfeld, G., Karlsson, A., Putkonen, P. O. & Wasserman, J. (1987). Oral Candida albicans in HIV infection. Scandinavian Journal of Infectious Diseases 19, 291-5.
4. British Society for Antimicrobial Chemotherapy Working Party. (1992). Antifungal chemotherapy in patients with acquired immunodeficiency syndrome. Lancet 340, 648-51.
5. Hood, S. & Denning, D. W. (1996). Treatment of fungal infection in AIDS. Journal of Antimicrobial Chemotherapy 37, Suppl. B, 71-85.
6. Barchiesi, F., Hollis, R. J., McGough, D. A., Scalise, G., Rinaldi, M. G. & Pfaller, M. A. (1995). DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS. Clinical Infectious Diseases 20, 634-40.
7. Bart-Delabesse, E., Boiron, P., Carlotti, A. & Dupont, B. (1993). Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. Journal of Clinical Microbiology 31, 2933-7.
8. Boken, D. J., Swindells, S. & Rinaldi, M. G. (1993). Fluconazole-resistant Candida albicans. Clinical Infectious Diseases 17, 1018-21.
9. Cormican, M. G. & Pfaller, M. A. (1996). Standardization of antifungal susceptibility testing. Journal of Antimicrobial Chemotherapy 38, 561-78.
10. Johnson, E. M. & Warnock, D. W. (1995). Azole drug-resistance in yeasts. Journal of Antimicrobial Chemotherapy 36, 751-5.
11. Johnson, E. M., Warnock, D. W., Luker, J., Porter, S. R. & Scully, C. (1995). Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. Journal of Antimicrobial Chemotherapy 35, 103-14.
12. Millon, L., Manteaux, A., Reboux, G., Drobacheff, C., Monod, M., Barale, T. et al. (1994). Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. Journal of Clinical Microbiology 32, 1115-8.
13. Odds, F. C. (1993). Resistance of yeasts to azole-derivative antifungals. Journal of Antimicrobial Chemotherapy 31, 463-71.
14. Pfaller, M. A., Rhine-Chalberg, J., Redding, S. W., Smith, J., Farinacci, G., Fothergill, A. W. et al. (1994). Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. Journal of Clinical Microbiology 32, 59-64.
15. Redding, S., Smith, J., Farinacci, G., Rinaldi, M., Fothergill, A., Rhine-Chalberg, J. et al. (1994). Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clinical Infectious Diseases 18, 240-2.
16. Rex, J. H., Rinaldi, M. G. & Pfaller, M. A. (1995). Resistance of Candida species to fluconazole. Antimicrobial Agents and Chemotherapy 38, 1-8.
17. Como, J. A. & Dismukes, W. E. (1994). Oral azole drugs as systemic antifungal therapy. New England Journal of Medicine 330, 263-72.
18. Sangeorzan, J. A., Bradley, S. F., He, X., Zarins, L. T., Ridenour, G. L., Tiballi, R. N. et al. (1994). Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. American Journal of Medicine 97, 339-46.
19. Boerlin, P., Boerlin-Petzold, F., Goudet, J., Durussel, C., Pagani, J. L., Chave, J. P. et al. (1996). Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting. Journal of Clinical Microbiology 34, 1235-48.
20. Espinel-Ingroff, A., Quart, A., Steele-Moore, L., Metcheva, I., Buck, G. A., Bruzzese, V. L. et al. (1996). Molecular karyotyping of multiple yeast species isolated from nine patients with AIDS during prolonged fluconazole therapy. Journal of Medical and Veterinary Mycology 34, 111-6.
21. Le Guennec, R., Reynes, J., Mallié, M., Pujol, C., Janbon, F. & Bastide, J. M. (1995). Fluconazole-and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities. Journal of Clinical Microbiology 33, 2732-7.
22. Powderly, W. G., Robinson, K. & Keath, E. J. (1992). Molecular typing of Candida albicans isolated from oral lesions of HIV-infected individuals. AIDS 6, 81-4.
23. Powderly, W. G., Robinson, K. & Keath, E. K. (1993). Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. Journal of Infectious Diseases 168, 463-6.
24. Schmid, J., Odds, F. C., Wiselka, M. J., Nicholson, K. G. & Soll, D. R. (1992). Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. Journal of Clinical Microbiology 30, 935-41.
25. Reynes, J., Pujol, C., Moreau, C., Mallié, M., Renaud, F., Janbon, F. et al. (1996). Simultaneous carriage of Candida albicans strains from HIV-infected patients with oral candidiasis: multilocus enzyme electrophoresis analysis. FEMS Microbiology Letters 137, 269-73.
26. Warren, N. G. & Shadomy, H. J. (1991). Yeasts of medical importance. In Manual of Clinical Microbiology, 5th edn (Balows, A., Hausler, W. J., Herrmann, K. L., lsenberg, H. D. & Shadomy, H. J., Eds) pp. 617-29. American Society for Microbiology, Washington, DC.
27. National Committee for Clinical Laboratory Standards. (1995). Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts: Tentative Standard M27-T. NCCLS, Wayne, PA.
28. Pfaller, M. A., Bale, M., Buschelman, B., Lancaster, M., Espinel-Ingroff, A., Rex, J. H. et al. (1994). Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods. Journal of Clinical Microbiology 32, 1650-3.
29. Baily, G. G., Perry, F. M., Denning, D. W. & Mandal, B. K. (1994). Fluconazole-resistant candidosis in an HIV cohort. AIDS 8, 787-92.
30. Plettenburg, A., Stoehr, A., Hoffken, G., Bergs, C., Tschechne, B., Ruhnke, W. et al. (1994). Fluconazole therapy of oral candidiasis in HIV infected patients: results of a multicenter study. Infection 22, 118-23.
31. Cameron, M. L., Schell, W. A., Bruch, S., Bartlett, J. A., Waskin, H. A. & Perfect, J. R. (1993). Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrobial Agents and Chemotherapy 37, 2449-53.
32. Ng, T. T. & Denning, D. W. (1993). Fluconazole resistance in Candida in patients with AIDS - a therapeutic approach. Journal of Infection 26, 117-25.
33. Rodriguez-Tudela, J. L., Martinez-Suarez, J. V., Dronda, F., Laguna, F., Chaves, F. & Valencia, E. (1995). Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients. Journal of Antimicrobial Chemotherapy 35, 793-804.
34. Ruhnke, M., Eigler, A., Engelmann, E., Geiseler, B. & Trautmann, M. (1994). Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole. Infection 22, 132-6.
35. Troillet, N., Durussel, C., Bille, J., Glauser, M. P. & Chave, J. P. (1993). Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. European Journal of Clinical Microbiology and Infectious Diseases 12, 911-5.
36. Barchiesi, F., Morbiducci, V., Ancarani, F. & Scalise, G. (1993). Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients. European Journal of Epidemiology 9, 455-6.
37. Dronda, F., Alonso-Sanz, M., Laguna, F., Chaves, F., Martinez-Suarez, J. V., Rodriguez-Tudela, J. L. et al. (1996). Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients. European Journal of Clinical Microbiology and Infectious Diseases 15, 446-52.
38. Powderly, W. G. (1992). Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients. AIDS 6, 604-5.
39. Iwaguchi, S., Homma, M. & Tanaka, K. (1992). Clonal variation of chromosome size derived from the rDNA cluster region in Candida albicans. Journal of General Microbiology 138, 1177-84.
40. Barchiesi, F., Hollis, R. J., Del Poeta, M., McGough, D. A., Scalise, G., Rinaldi, M. G. et al. (1995). Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis. Clinical Infectious Diseases 21, 561-4.
41. Miyasaki, S. H., Hicks, J. B., Greenspan, D., Polacheck, I., MacPhail, L. A., White, T. C. et al. (1992). The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals. Journal of Acquired Immune Deficiency Syndromes 5, 1039-46.